RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
BLOOD CANCER JOURNAL
Collezione AOU Novara

Items : 6

Breakthrough infections in MPN-COVID vaccinated patients. in Blood cancer journal / Blood Cancer J. 2022 Nov 15;12(11):154. doi: 10.1038/s41408-022-00749-8.

2022
AOU Città della Salute di Torino
AOU Novara

Curto-Garcia N; Carbonell S; Cavalca F; Borsani O; Bucelli C; Betti S; Kulikowska de Na??cz A; Cattaneo D; Guenova M; Navas Elorza B; Cichocka E; Angona A; Kusec R; Xicoy Cirici B; Sagues Serrano M; Carli G; Lopez Abadia E; Sanchez AM; Hernandez-Boluda JC; Garcia-Gutierrez V; Quiroz Cervantes K; Griesshammer M; Heidel FH; Bolaños Calderón E; Kiladjian JJ; Koschmieder S; Magro Mazo E; Foncillas MA; Osorio S; et alii...

Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase? 2 trial. in Blood cancer journal / Blood Cancer J. 2022 Jan 24;12(1):9. doi: 10.1038/s41408-021-00593-2.

2022
AOU Novara

Dimopoulos MA; Schjesvold F; Doronin V; Vinogradova O; Quach H; Leleu X; Montes YG; Ramasamy K; Pompa A; Levin MD; Lee C; Mellqvist UH; Fenk R; Demarquette H; Sati H; Vorog A; Labotka R; Du J; Darif M; Kumar S;

Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients. in Blood cancer journal / Blood Cancer J. 2022 Jan 18;12(1):8. doi: 10.1038/s41408-022-00608-6.

2022
AOU Alessandria
AO Cuneo
AOU Novara

Gariglio M; Massaia M; Gaidano G; Ladetto M; Lai M; Pistello M; Rapezzi D; Marchetti M; Mahmoud AM; Gaidano V; Patriarca A; Ferrante D; Borgogna C; Bruna R; Griffante G; Martuscelli L; De Andrea M;

Long-term follow-up of recovered MPN patients with COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Jun 16;11(6):115. doi: 10.1038/s41408-021-00509-0.

2021
AOU Città della Salute di Torino
AOU Novara

Guglielmelli P; Benajiba L; Bellosillo B; Cavalca F; Curto-Garcia N; Garrote M; Bellini M; Daffini R; Sobas MA; Cattaneo D; Cuevas B; Koschmieder S; Ruggeri M; Xicoy Cirici B; Angona A; Lopez Abadia E; Hernandez-Boluda JC; De Stefano V; Lunghi F; Bonifacio M; Garcia-Gutierrez V; Magro Mazo E; Navas Elorza B; Patriarca A; Rumi E; Osorio S; Benevolo G; Fox ML; Sagues Serrano M; et alii...

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Feb 4;11(2):21. doi: 10.1038/s41408-021-00417-3.

2021
AOU Città della Salute di Torino
AOU Novara

Harrison C; Rambaldi A; Bellini M; Betti S; Bellosillo B; Benajiba L; Curto-Garcia N; Cavalca F; Daffini R; Cattaneo D; Garrote M; Guglielmelli P; Cirici BX; Cuevas B; Hernandez-Boluda JC; Abadia EL; Carli G; Koschmieder S; Mazo EM; Angona A; Lunghi F; Patriarca A; Elorza BN; Sobas MA; Serrano MS; Carreno-Tarragona G; Bonifacio M; Cervantes KSQ; Osorio S; et alii...

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab. in Blood cancer journal / Blood Cancer J. 2020 Sep 16;10(9):92. doi: 10.1038/s41408-020-00358-3.

2020
AOU Città della Salute di Torino
AOU Novara

Di Raimondo F; Fronza G; Cutrona G; Neri A; Bomben R; Angeletti I; D'Arrigo G; Tripepi G; Vitale C; Al-Janazreh H; Zucchetto A; Rossi FM; Scortechini I; Consoli U; Loseto G; Pietrasanta D; Recchia AG; Moia R; Bossio S; Mendicino F; Lucia E; Vigna E; Chiarenza A; Varettoni M; Murru R; Laurenti L; Mauro FR; Sportoletti P; Reda G; et alii...